Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows
July 02, 2020
DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System.
In a large-scale retrospective analysis of 2,541 patients hospitalized between March 10 and May 2, 2020 across the system’s six hospitals, the study found 13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine. None of the patients had documented serious heart abnormalities; however, patients were monitored for a heart condition routinely pointed to as a reason to avoid the drug as a treatment for COVID-19.
The study was published today in the International Journal of Infectious Diseases, the peer-reviewed, open-access online publication of the International Society of Infectious Diseases (ISID.org).
Patients treated with hydroxychloroquine at Henry Ford met specific protocol criteria as outlined by the hospital system’s Division of Infectious Diseases. The vast majority received the drug soon after admission; 82% within 24 hours and 91% within 48 hours of admission. All patients in the study were 18 or over with a median age of 64 years; 51% were men and 56% African American
Thank you for that. Did you read up on the retracted Lancet study posted in the new england journal of medicine that caused the emergency order to be halted and caused many governors to ban HCQ? Let me grab that one for you.
i believe these numbers were commented on here https://www.nejm.org/doi/full/10.1056/NEJMc2023617?query=recirc_curatedRelated_articleWhen taken within 2,3,4 days within exposure, cases are reduced by 49%, 29%, 16%.
yeah read it a long time ago
did you know we used to try to do bone marrow transplants on breast cancer patients due to falsified data as well?
people try to game the system to get fame. it doesn't make NEJM any less prestigious.
i believe these numbers were commented on here https://www.nejm.org/doi/full/10.1056/NEJMc2023617?query=recirc_curatedRelated_article
1. first, the big numbers like 49%, these are relative reductions. the translated absolute reduction is ~7%.
2. the letter then addresses the size of the trial needed and the potential absolute reduction in incidence, which is from 15% to 12.5%. that is treating 8000 people to maybe have an effect on about 200 of them.
3. you might think to yourself, well that doesn't seem so bad, 8000/200 is like treating 40 to change 1 to reduce symptoms.
4. wait what. you're treating FORTY people to reduce ONE PERSON'S symptoms? and you're doing all of this WITHOUT A MORTALITY BENEFIT? of course nobody is going to buy into this crap. you're better off mandating people wear masks and staying at home than telling them to take these meds.
Does he have any financial stake in this?
retrospective analysis with demographics showing 20 different categories of significant differences between the treatment arms and you're wondering why this paper didn't get more press coverage?
is this a joke?
studies aren't designed to be against a drug. HCQ studies are designed to detect a benefit if it is randomized against placebo or designed to be non-inferior if there is a known intervetion or standard of care that is already set. you have some weird interpretation of how actual science is conducted and it's blatantly obvious.I can argue similar points against the studies against HCQ. There is no perfect study to show 100% scientific certainty either way.
studies aren't designed to be against a drug. HCQ studies are designed to detect a benefit if it is randomized against placebo or designed to be non-inferior if there is a known intervetion or standard of care that is already set. you have some weird interpretation of how actual science is conducted and it's blatantly obvious.
show me a randomized controlled trial that has a demographics table as unbalanced as that retrospective analysis
the whole point of randomization, when done properly, is to make sure the two (or more) experimental groups are even, so that you avoid confounders like one group having more older people, etc. that might have an impact on the outcome.
honestly, if you don't believe in the current medical system and how they conduct research and develop guidelines, go find your local alternative medicine healer and just remove yourself from the health care system entirely.
i'm giving you a snide remark because when discussing the validity of clinical trials and then reverting to your personal anecdote of a sample of one or all of these other small trials or papers, you're just jumping platforms of what we're actually discussing.
clinical trials are designed to find the best treatment option for a POPULATION of people, meaning, serving the benefit to the highest percentage. it does NOT GUARANTEE EVERY INDIVIDUAL will benefit the guideline. this country is too heterogenous for that to ever happen. i'm sorry the guidelines don't work for you, but they worked for a lot more people than it didn't.
posted the credentials of a yale faculty member? good for him. guess what. if his paper was so good, his PEERS are to decide whether or not it deserves to be amongst the higher impact journals. academic medicine is a meritocracy. are there biases and influence? absolutely. but at the end of the day, if scientist X publishes experiment A, and then scientist Y is unable to replicate the results, then the COMMUNITY has a discussion on why the two outcomes are different. If scientist Y has the same results, then the community is likely to agree to the efficacy of the intervention.
all these internet wannabe academics putting x, y, and z together like they are some medical researcher is a waste of energy. your work, at the end of the day, will have zero impact on the guidelines.
if HCQ was so undoubtedly good, there would be no way to falsify the data. at the end of the day, the efficacy is questionable and there is enough data out there currently to suggest that the likelihood if anyone replicating any positive findings is very, very small.
HCQ + cocktail is definitely a good solution to the Chinese virus, not perfect, but when used wisely, is very effective.
It shows you how far the globalist/socialist/Democtat machine will go to take power in this country, they have ordered the media/press/Hollywood/social media giant to disparage the product, they have smeared all communications with misinformation and disinformation about HCQ = cocktail.
The people cannot have hope against this virus... the people must remain desperate: at least until November 4th.
(additionally, long story short, the CDC/NIH/FDA are not reliable at all these days)
i'm giving you a snide remark because when discussing the validity of clinical trials and then reverting to your personal anecdote of a sample of one or all of these other small trials or papers, you're just jumping platforms of what we're actually discussing.
clinical trials are designed to find the best treatment option for a POPULATION of people, meaning, serving the benefit to the highest percentage. it does NOT GUARANTEE EVERY INDIVIDUAL will benefit the guideline. this country is too heterogenous for that to ever happen. i'm sorry the guidelines don't work for you, but they worked for a lot more people than it didn't.
posted the credentials of a yale faculty member? good for him. guess what. if his paper was so good, his PEERS are to decide whether or not it deserves to be amongst the higher impact journals. academic medicine is a meritocracy. are there biases and influence? absolutely. but at the end of the day, if scientist X publishes experiment A, and then scientist Y is unable to replicate the results, then the COMMUNITY has a discussion on why the two outcomes are different. If scientist Y has the same results, then the community is likely to agree to the efficacy of the intervention.
all these internet wannabe academics putting x, y, and z together like they are some medical researcher is a waste of energy. your work, at the end of the day, will have zero impact on the guidelines.
if HCQ was so undoubtedly good, there would be no way to falsify the data. at the end of the day, the efficacy is questionable and there is enough data out there currently to suggest that the likelihood if anyone replicating any positive findings is very, very small.
i believe these numbers were commented on here https://www.nejm.org/doi/full/10.1056/NEJMc2023617?query=recirc_curatedRelated_article
1. first, the big numbers like 49%, these are relative reductions. the translated absolute reduction is ~7%.
2. the letter then addresses the size of the trial needed and the potential absolute reduction in incidence, which is from 15% to 12.5%. that is treating 8000 people to maybe have an effect on about 200 of them.
3. you might think to yourself, well that doesn't seem so bad, 8000/200 is like treating 40 to change 1 to reduce symptoms.
4. wait what. you're treating FORTY people to reduce ONE PERSON'S symptoms? and you're doing all of this WITHOUT A MORTALITY BENEFIT? of course nobody is going to buy into this crap. you're better off mandating people wear masks and staying at home than telling them to take these meds.
How did Tamiflu become the standard of care for the flu? That was a massive shit show. How long did it take the CDC to admit the shit doesn't work like they've claimed for years? How many Billions of dollars later? You tell us to trust the data and these esteemed medical professionals but they again and again get caught manipulating the study or data to their benefit.
They also pushed through Remdesivir through without the standards you you mention above. It's got the next Tamiflu written all over it.
My work at the end of day saved my life by trying to find an answer to an infectious disease much more devastating than Covid. I've also helped other long time tick borne disease sufferers get healthy when the best doctors in the country couldn't.
?@)
DO NOT open if u believe govt has an evil plan ;
https://www.covid19treatmentguideli...therapy/hydroxychloroquine-plus-azithromycin/
Clinical Trials
Clinical trials that are testing the safety and efficacy of chloroquine or hydroxychloroquine with or without azithromycin in people who have or who are at risk for COVID-19 are underway in the United States and internationally. Please check ClinicalTrials.gov for the latest information.
[h=2]Recommendation[/h]
- The COVID-19 Treatment Guidelines Panel recommends against using hydroxychloroquine plus azithromycin for the treatment of COVID-19, except in a clinical trial (AIII).